investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Biology and Prognostic Implications of FLT3 Mutations in AML
Soheil Meshinchi
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Soheil Meshinchi
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
Catherine Ju-Ying Wu
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
Leukaemia
Alan Rein
Retrovirus Assembly and Maturation – Rockville
Leukaemia
Pathology
Hematology and hematologic malignancies
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Pathology
Hematology and hematologic malignancies
Luca Gattinoni
Programming T Cell Fates for Therapeutic Use
Leukaemia
Pathology
Hematology and hematologic malignancies
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Pathology
Hematology and hematologic malignancies
Charles G Mullighan
Functional analysis of leukemic CREBBP mutations
Leukaemia
Pediatric oncology or childhood cancer
Julia Kubanek
Ecological Leads for Drug Discovery from Marine Organisms
Leukaemia
Charalampos Kalodimos
Mechanisms of autoinhibition and activation of the Abl kinase
Leukaemia